Third-Party Review Process Gaining Agency Support, FDA Official Says
This article was originally published in The Gray Sheet
Medical device reviews by third parties are gaining support inside FDA as the agency looks to reduce review times with fewer resources, Center for Devices and Radiological Health International Staff Director Ronald Parr remarked at a Sept. 22 MassMEDIC conference in Waltham, Massachusetts.
You may also be interested in...
Third-party 510(k) submissions are gaining FDA clearance at over three times the rate of comparable submissions made directly to the agency, Eric Rechen, a staffer in FDA's Office of Device Evaluation, said.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.